Europe Drug Delivery Market Forecast to 2028– COVID-19 Impact and Regional Analysis– by Route of Administration (Injectable Drug Delivery, Oral Drug Delivery, Transmucosal Drug Delivery, Topical Drug Delivery, Implantable Drug Delivery, and Ocular Drug De

Europe Drug Delivery Market Forecast to 2028– COVID-19 Impact and Regional Analysis– by Route of Administration (Injectable Drug Delivery, Oral Drug Delivery, Transmucosal Drug Delivery, Topical Drug Delivery, Implantable Drug Delivery, and Ocular Drug Delivery), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and End User (Hospitals and Clinics, Home Care Settings, and Other End User)

The Europe drug delivery market is expected to grow from US$ 6,32,268.46 million in 2023 to US$ 8,95,338.87 million by 2028. It is estimated to grow at a CAGR of 7.2% from 2023 to 2028.

Growing Demand for Noninvasive Drug Delivery Systems Fuel Europe Drug Delivery Market

Noninvasive drug delivery generally refers to methods of painless drug delivery across the biological barriers of mucosal surfaces or skin. This drug delivery method could lead to improved access to medicines, adherence to treatment regimes, and better drug safety profiles. Patients prefer noninvasive drug delivery routes due to such apparent advantages over injection-based drug administration. Patient compliance has been found to be much higher when drugs are administrated by noninvasive methods, as they experience decreased pain during the procedure. With improvements in medical devices and transdermal delivery technologies, the noninvasive mode of drug delivery is now ready to compete with traditional methods of oral and injectable routes of drug delivery. Topical, transdermal-active (device-aided enhanced penetration), transdermal-passive, trans-ocular membrane, trans-mucosal membrane, and delivery via an alveolar membrane from inhaled medication are a few of the popular noninvasive drug delivery methods.

A low rejection rate, ease of administration, convenience, and durability make TDDS the most attractive method of drug delivery. In addition to pharmaceutical administration in medical facilities, TDDS could be used in different procedures in the skincare industry. Since this method mainly involves local administration, it can prevent nonspecific delivery to tissues that are not targeted by the drug. Developments in TDDS are likely to help control the prevalence of cardiovascular and central nervous system disorders, genetic disorders, diabetes, neuromuscular disorders, and infectious (including localized conditions) diseases while driving advancements in vaccination and patient preference for self-administration of drugs for long-term treatment.

Drug delivery through noninvasive methods involves reduced dosing frequency and simplified dosing schedules. Moreover, these delivery systems can significantly reduce the cost of clinical use as patients can self-administer drugs via these methods. In many cases, the manufacturing cost of drugs with noninvasive delivery systems is lesser than the production costs of injections. For instance, inhaled insulin has emerged as a well-tolerated and preferred modality for treating diabetes. Thus, the growing demand for noninvasive drug delivery systems propels the growth of the drug delivery systems market.

Europe Drug Delivery Market Overview

The Europe drug delivery market is sub segmented into Germany, France, Italy, the UK, Spain, and the Rest of Europe. The market growth in this region is associated with rise in incidences of chronic diseases, increase in the geriatric population, expansion strategies by the market players, and growth of the pharmaceutical industry. Germany is known for its technological advancements, leading the country to the forefront in the medical & healthcare sectors. German companies such as Haselmeier have developed the D-Flex pen, a drug delivery device that works more efficiently than previously developed injection pens. The pen is the next-generation drug delivery device for subcutaneous self-injection. The multi-dose fixed pen can administer the drug in a single fixed dose or several pre-set doses; therefore, it is preferred over conventional drug delivery devices.

Europe Drug Delivery Market Revenue and Forecast to 2028 (US$ Million)

Europe Drug Delivery Market Segmentation

The Europe drug delivery market is segmented into route of administration, distribution channel, end user, and country.

Based on route of administration, the Europe drug delivery market is segmented into injectable drug delivery, oral drug delivery, transmucosal drug delivery, topical drug delivery, implantable drug delivery, and ocular drug delivery. The injectable drug delivery segment held a larger share of the Europe drug delivery market in 2023.

Based on distribution channel, the Europe drug delivery market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment held the largest share of the Europe drug delivery market in 2023.

Based on end user, the Europe drug delivery market is segmented into hospitals and clinics, home care settings, and other end user. The hospitals and clinics segment held the largest share of the Europe drug delivery market in 2023.

Based on country, the Europe drug delivery market is segmented into Germany, France, the UK, Italy, Spain, and the Rest of Europe. Germany dominated the share of the Europe drug delivery market in 2023.

Bausch Health Companies Inc; Baxter International Inc; Becton Dickinson and Co; Boehringer Ingelheim International GmbH; Boston Scientific Corp; Gerresheimer AG; GlaxoSmithKline Plc; Johnson & Johnson; Novartis AG; Novo Nordisk AS; Pfizer Inc; and Sever Pharma Solutions are the leading companies operating in the Europe drug delivery market.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe drug delivery market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in Europe drug delivery market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.